心臟安全服务市场规模、份额、成长分析（按服务、按类型、按最终用途、按地区）- 产业预测 2025-2032

预计全球心臟安全服务市场在 2023 年的价值将达到 7.4 亿美元，到 2032 年将从 2024 年的 8.2436 亿美元增长到 19.5523 亿美元，在预测期内（2025-2032 年）的复合年增长率为 11.4%。

心血管疾病的预防，加上药物开发活动和监管要求的增加，正在显着推动全球心臟安全服务市场的发展。外包服务的趋势和心电图数据分析的进步进一步刺激了这项需求。此外，人工智慧与心臟安全监测的结合预计将推动市场成长。随着临床试验的增加和对早期发现心血管风险的需求的增长，服务供应商正在扩大其提供的服务范围，包括有助于即时心臟评估的综合心电图和远端检测服务。强调集中心臟安全资料集中并与临床系统无缝集成，可以简化临床试验、降低风险，并使外包心臟安全服务成为希望加快监管核准的製药和生物技术公司的一个有吸引力的选择。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术分析
• 顾客购买行为分析

心臟安全服务市场规模（依服务及复合年增长率）（2025-2032）

• 市场概览
• 心电图/心电图监测
• 血压计
• 心血管影像
• 其他的

心臟安全服务市场规模（按类型及复合年增长率）（2025-2032）

• 市场概览
• 融合的
• 独立

心臟安全服务市场规模（依最终用途及复合年增长率）（2025-2032 年）

• 市场概览
• 製药和生物製药公司
• CRO
• 其他的

心臟安全服务市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 按部门分類的公司份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• IQVIA
• PPD Inc,
• Charles River Laboratories
• Welly sis
• Eurofins Scientific
• Celerion
• Nova Research Laboratories
• Laboratory Corporation of America Holdings
• Konin klije Philips NV
• ICON Plc.
• SGS SA
• Clario
• Viva Link
• Certara
• Richmond Pharmacology
• Biotrial

结论和建议

Global Cardiac Safety Services Market size was valued at USD 740.0 million in 2023 and is poised to grow from USD 824.36 million in 2024 to USD 1955.23 million by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

The growing prevalence of cardiovascular diseases, coupled with heightened drug development activities and regulatory demands, is significantly boosting the global cardiac safety services market. The trend towards outsourcing services and advancements in ECG data analysis further enhances this demand. Additionally, the integration of artificial intelligence into cardiac safety monitoring is expected to propel market growth. As clinical trials increase and the need for early cardiovascular risk detection becomes more pressing, service providers are broadening their offerings, including comprehensive ECG and telemetry services, facilitating real-time cardiac assessments. The emphasis on centralized cardiac safety data and seamless integration with clinical systems will enhance trial efficiencies and reduce risks, making outsourcing of cardiac safety services an attractive option for pharmaceutical and biotechnology clients aiming to expedite regulatory approvals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Safety Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Safety Services Market Segments Analysis

Global Cardiac Safety Services Market is segmented by Services, Type, End Use and region. Based on Services, the market is segmented into ECG/Holter Monitors, Blood Pressure Monitors, Cardiovascular Imaging and Others. Based on Type, the market is segmented into Integrated and Standalone. Based on End Use, the market is segmented into Pharma & Biopharma Companies, CROs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Safety Services Market

The increasing momentum in drug development, particularly within cardiovascular, oncology, and central nervous system therapies, underscores the growing necessity for cardiac safety monitoring. This heightened focus is driven by the stringent requirements imposed by regulatory bodies, necessitating comprehensive cardiac safety evaluations. As a result, there is a pronounced demand for specialized services that encompass ECG and Holter monitoring, as well as QT interval assessments. This trend reflects the industry's commitment to ensuring patient safety and the efficacy of new therapies, further reinforcing the importance of expert cardiac safety services in the drug development process.

Restraints in the Global Cardiac Safety Services Market

The Global Cardiac Safety Services market faces significant challenges due to the substantial investment required for the implementation of advanced ECG monitoring systems, telemetry devices, and AI-driven analytics platforms. This financial burden can raise the costs associated with cardiac safety services, particularly impacting small and mid-sized pharmaceutical companies. As a result, the heightened expenses may deter these companies from investing in necessary technologies and services, ultimately hindering the overall growth potential of the market. The interplay between technological advancements and financial limitations creates a restraint that may affect market dynamics and innovation.

Market Trends of the Global Cardiac Safety Services Market

The Global Cardiac Safety Services market is experiencing a notable shift towards decentralized clinical trials, significantly enhancing the adoption of remote cardiac monitoring solutions. This trend is characterized by an increased reliance on wearable ECG devices, mobile health applications, and cloud-based telemetry platforms, allowing for the efficient capture of cardiac data beyond conventional clinical environments. As a result, participants enjoy greater convenience, and researchers can access larger and more diverse participant pools while streamlining data collection processes. This evolution not only improves the overall efficiency of cardiac safety assessments but also aligns with the growing demand for innovative digital health solutions in clinical research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis
• Customer Buying Behavior Analysis

Global Cardiac Safety Services Market Size by Services & CAGR (2025-2032)

• Market Overview
• ECG/Holter Monitors
• Blood Pressure Monitors
• Cardiovascular Imaging
• Others

Global Cardiac Safety Services Market Size by Type & CAGR (2025-2032)

• Market Overview
• Integrated
• Standalone

Global Cardiac Safety Services Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharma & Biopharma Companies
• CROs
• Others

Global Cardiac Safety Services Market Size & CAGR (2025-2032)

• North America (Services, Type, End Use)
  • US
  • Canada
• Europe (Services, Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Services, Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Services, Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Services, Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IQVIA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD Inc,
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welly sis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celerion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Research Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Konin klije Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clario
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viva Link
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richmond Pharmacology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotrial
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations